Novo Holdings hot on diagnostics: This is the key to unlocking two of the largest healthcare issues
Investing in diagnostics is complicated, even for Novo Holdings – but due to the potential in the industry, the company is hungry for more acquisitions, after completing its largest-ever investment in a diagnostics company on Tuesday.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Through the acquisition of Welsh BBI group on Tuesday, Novo Holdings is demonstrating that the diagnostics area is an important field of interest for the Danish life science investor.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings acquires diagnostics company for USD 564m
For subscribers
